Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1743studies shown

Showing 685-696 of 1,743

Drug study icon

CompletedNCT01972711

Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United Kingdom
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00086593

An FDA-approved Drug As Additional Therapy In people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Canada, United Kingdom
Sponsor: GlaxoSmithKline
Condition: Schizophrenia

Drug study icon

CompletedNCT00257972

Aripiprazole in people with Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

BipolarityDrugOver 18 Years

Countries: United States, Australia, France, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT00191659

Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

ADHDDrugFrom 7 Years to 15 Years

Countries: United Kingdom
Sponsor: Eli Lilly and Company
Condition: ADHD

Drug study icon

CompletedNCT01716975

EVP-6124 (Alpha-7 nAChR) for schizophrenia

This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.

In United Kingdom

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States, Australia, United Kingdom, ...
Sponsor: FORUM Pharmaceuticals Inc
Condition: Schizophrenia

Biological study icon

CompletedNCT02449746

Immunotherapy in Autoantibody Positive Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

SchizophreniaBiologicalFrom 18 Years to 65 Years

Countries: United Kingdom
Sponsor: University of Cambridge
Condition: Schizophrenia

Drug study icon

CompletedNCT02731612

the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

BipolarityDrugFrom 19 Years to 65 Years

Countries: United States, Canada, United Kingdom, ...
Sponsor: Lakshmi N Yatham
Condition: Bipolarity

Drug study icon

CompletedNCT00501865

Effect of Food on the Concentration of GW273225 for Bipolarity

This study is completed in the United Kingdom. It is testing Effect of Food on the Concentration of GW273225 for Bipolarity.

In United Kingdom

BipolarityDrugFrom 18 Years to 55 Years

Countries: United Kingdom
Sponsor: GlaxoSmithKline
Condition: Bipolarity

Drug study icon

CompletedNCT03187769

Efficacy of ALKS 3831 on Body Weight for schizophrenia

This study is completed in the United States, in the United Kingdom, in Austria, .... It is testing Efficacy of ALKS 3831 on Body Weight for schizophrenia.

In United Kingdom

Bipolarity, SchizophreniaDrugFrom 16 Years to 40 Years

Countries: United States, United Kingdom, Austria, ...
Sponsor: Alkermes, Inc.
Condition: Bipolarity, Schizophrenia

Drug study icon

CompletedNCT03201757

Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

This study is completed in the United States, in the United Kingdom, in Austria, .... It focuses on Schizophrenia.

In United Kingdom

Schizophrenia, BipolarityDrugFrom 16 Years to 70 Years

Countries: United States, United Kingdom, Austria, ...
Sponsor: Alkermes, Inc.
Condition: Schizophrenia, Bipolarity

Behavioral study icon

CompletedNCT06698588

Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

ADHDBehavioralFrom 5 Years to 12 Years

Countries: United Kingdom
Sponsor: Swansea University
Condition: ADHD

Drug study icon

CompletedNCT05870501

Synaptic Imaging and Network Activity in Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

Depression, BipolarityDrugFrom 18 Years to 55 Years

Countries: United Kingdom
Sponsor: King's College London
Condition: Depression, Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.